Inventor · disambiguated record
Curt A. Dvorak
Also filed as: DVORAK CURT · DVORAK CURT A
44 granted patents·7 pending applications·234 citations·filing 2002–2024
98Inventor score
Files withJANSSEN PHARMACEUTICA NV43BONAVENTURE PASCAL2DVORAK CURT A2CHAI WENYING1JANSSEN PHARMACEUTICA N Y1
Top patents by PatentIndex Score
51 records- 0196US11214563B2Substituted pyrazolo-pyrazines and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 4, 2022·4 cites·26 claims
- 0296US9464084B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 11, 2016·16 cites·6 claims
- 0395US9066946B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·20 cites·32 claims
- 0494US10150765B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Dec 11, 2018·11 cites·18 claims
- 0594US10071988B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Sep 11, 2018·17 cites·22 claims
- 0693US10233173B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 19, 2019·13 cites·20 claims
- 0792US11820770B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 21, 2023·1 cites·20 claims
- 0891US10112937B2P2X7 modulators and methods of useJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 30, 2018·11 cites·40 claims
- 0991US7598255B2Pyrimidine compounds as serotonin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Oct 6, 2009·16 cites·11 claims
- 1090US12247027B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Mar 11, 2025·0 cites·10 claims
- 1189US11530210B2Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 20, 2022·2 cites·129 claims
- 1289US11447503B2Pyridine carbamates and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 20, 2022·2 cites·33 claims
- 1389US11161846B2Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 2, 2021·2 cites·26 claims
- 1489US6803362B2Heterocyclic compoundsORTHO MCNEIL PHARM INC·Filed 2002·Granted Oct 12, 2004·38 cites·37 claims
- 1588US7226938B2Heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jun 5, 2007·30 cites·2 claims
- 1686US11225478B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 18, 2022·1 cites·46 claims
- 1786US9062078B2Substituted 7-azabicyles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 23, 2015·7 cites·88 claims
- 1885US10766880B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Sep 8, 2020·2 cites·27 claims
- 1985US9611262B2Substituted 2-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Apr 4, 2017·6 cites·18 claims
- 2083US10703749B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 7, 2020·1 cites·6 claims
- 2182US9265770B21,2,5-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 23, 2016·3 cites·11 claims
- 2282US7579470B2Fused heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 25, 2009·3 cites·2 claims
- 2381US8952177B21,2,6-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 10, 2015·4 cites·9 claims
- 2480US9067917B21,2,5-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·3 cites·9 claims
- 2579US9089569B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 28, 2015·3 cites·13 claims
- 2679US8883808B2Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapyBONAVENTURE PASCAL·Filed 2006·Granted Nov 11, 2014·8 cites·15 claims
- 2778US8618288B2Pyrimidine compounds as serotonin receptor modulatorsDVORAK CURT A·Filed 2009·Granted Dec 31, 2013·3 cites·4 claims
- 2877US2025136598A1Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2973US12172997B2Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Dec 24, 2024·0 cites·22 claims
- 3073US8183239B2Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptorBONAVENTURE PASCAL·Filed 2006·Granted May 22, 2012·2 cites·35 claims
- 3171US9115117B2Substituted piperidine compounds and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 25, 2015·1 cites·57 claims
- 3271US7402680B2Fused heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Jul 22, 2008·4 cites·21 claims
- 3368US7897771B2Fused heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Mar 1, 2011·0 cites·2 claims
- 3467US11993587B2Substituted pyrazolo-pyrazines and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 28, 2024·0 cites·19 claims
- 3567US2023045960A1Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 3662US9637496B2Substituted 7-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 2, 2017·0 cites·110 claims
- 3761US9682971B21,2,5-Substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 20, 2017·0 cites·13 claims
- 3859US9695183B2Substituted 7-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 4, 2017·0 cites·22 claims
- 3959US9695149B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 4, 2017·0 cites·20 claims
- 4058US2022274984A1Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 4154US11618750B2Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Apr 4, 2023·0 cites·124 claims
- 4254US9611251B2Substituted piperidine compounds and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 4, 2017·0 cites·70 claims
- 4354US8338426B2Piperazinyl derivatives useful as modulators of the neuropeptide Y2 receptorDVORAK CURT A·Filed 2008·Granted Dec 25, 2012·0 cites·15 claims
- 4453US9475819B2Substituted 7-azabicycles and their use as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 25, 2016·0 cites·18 claims
- 4552US9682972B21,2,5-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 20, 2017·0 cites·12 claims
- 4652US2005085487A1Heterocyclic compoundsFiled 2004·Application pending·0 cites
- 4749US7645758B2Heterocyclic compoundsJANSSEN PHARMACEUTICA N Y·Filed 2007·Granted Jan 12, 2010·0 cites·2 claims
- 4848US2016022636A1Physiological ligands for gpr139JANSSEN PHARMACEUTICA NV·Filed 2014·Application pending·0 cites
- 4948US2014336216A1Physiological ligands for gpr139JANSSEN PHARMACEUTICA NV·Filed 2014·Application pending·0 cites
- 5047US2012015957A1Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptorCHAI WENYING·Filed 2008·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Curt A. Dvorak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →